Amyris, Inc. (AMRS) Reaches $5.28 After 6.00% Up Move; Pimco Corporate & Income Opportunity Fund (PTY)’s Sentiment Is 1.08

May 18, 2018 - By Maria Brooks

Amyris, Inc. (NASDAQ:AMRS) Logo

The stock of Amyris, Inc. (NASDAQ:AMRS) is a huge mover today! The stock increased 3.53% or $0.18 during the last trading session, reaching $5.28. About 370,577 shares traded. Amyris, Inc. (NASDAQ:AMRS) has declined 7.62% since May 18, 2017 and is downtrending. It has underperformed by 19.17% the S&P500.The move comes after 7 months positive chart setup for the $262.39M company. It was reported on May, 18 by We have $5.60 PT which if reached, will make NASDAQ:AMRS worth $15.74 million more.

Pimco Corporate & Income Opportunity Fund (PTY) investors sentiment decreased to 1.08 in Q4 2017. It’s down -0.31, from 1.39 in 2017Q3. The ratio has dropped, as 28 active investment managers opened new or increased equity positions, while 26 trimmed and sold holdings in Pimco Corporate & Income Opportunity Fund. The active investment managers in our database now own: 3.97 million shares, down from 4.06 million shares in 2017Q3. Also, the number of active investment managers holding Pimco Corporate & Income Opportunity Fund in top ten equity positions was flat from 0 to 0 for the same number . Sold All: 10 Reduced: 16 Increased: 20 New Position: 8.

Among 5 analysts covering Amyris Inc (NASDAQ:AMRS), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Amyris Inc had 14 analyst reports since November 10, 2015 according to SRatingsIntel. As per Thursday, January 25, the company rating was initiated by FBR Capital. H.C. Wainwright maintained the shares of AMRS in report on Monday, April 2 with “Buy” rating. The firm earned “Buy” rating on Friday, August 11 by H.C. Wainwright. The rating was maintained by Cowen & Co with “Market Perform” on Thursday, March 10. The rating was initiated by H.C. Wainwright on Tuesday, November 10 with “Buy”. As per Monday, September 18, the company rating was maintained by Cowen & Co. H.C. Wainwright maintained the stock with “Buy” rating in Wednesday, June 7 report. The company was maintained on Wednesday, August 16 by Cowen & Co. B. Riley & Co maintained the stock with “Buy” rating in Tuesday, March 20 report. The stock of Amyris, Inc. (NASDAQ:AMRS) earned “Hold” rating by Cowen & Co on Tuesday, November 28.

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company has market cap of $262.39 million. The firm uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable ingredients. It currently has negative earnings. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market.

More important recent Amyris, Inc. (NASDAQ:AMRS) news were published by: which released: “Future Outlook Of The Energy Industry And Amyris Inc (NASDAQ:AMRS)” on May 08, 2018, also published article titled: “Amyris Sustainable Lubricants Joint Venture Company, Novvi, and Chevron Enter Agreement To Develop and Bring To …”, published: “Amyris’ (AMRS) CEO John Melo on Q1 2018 Results – Earnings Call Transcript” on May 15, 2018. More interesting news about Amyris, Inc. (NASDAQ:AMRS) was released by: and their article: “Amyris, Inc. 2018 Q1 – Results – Earnings Call Slides” with publication date: May 15, 2018.

Another recent and important PIMCO Corporate & Income Opportunity Fund (NYSE:PTY) news was published by which published an article titled: “PTY: A 22% Premium Is Only For The Bold” on May 18, 2018.

The stock increased 0.28% or $0.05 during the last trading session, reaching $18.11. About 78,573 shares traded. PIMCO Corporate & Income Opportunity Fund (PTY) has risen 9.49% since May 18, 2017 and is uptrending. It has underperformed by 2.06% the S&P500.

Amyris, Inc. (NASDAQ:AMRS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.